NCT04894630 is a NA clinical trial of antimicrobial treatment in Infective Keratitis, sponsored by Minia University.

Who is sponsoring NCT04894630?

NCT04894630 is sponsored by Minia University.

What drugs are being tested in NCT04894630?

Interventions in NCT04894630: antimicrobial treatment.

What condition does NCT04894630 study?

NCT04894630 studies Infective Keratitis.

Is NCT04894630 still recruiting?

NCT04894630 is currently completed. Last updated 20 May 2021.

Last reviewed 2021-05-20 · How we verify

NCT04894630

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infective Keratitis in Minia Governate

Completed NA Last updated 20 May 2021

What this trial tests

NA trial testing antimicrobial treatment in Infective Keratitis in 150 participants. Completed in 31 December 2020.

Timeline

1 December 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	1 December 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

antimicrobial treatment

Conditions studied

Infective Keratitis — all drugs for Infective Keratitis →

Sponsor

Minia University

Who can join

Adults 12 to 80, any sex, with Infective Keratitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine the microbiological aetiology, epidemiological factors, and clinical profile and treatment outcomes of infective keratitis in Ophthalmology department, Minia University. Egypt

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Epidemiology, clinical profile and treatment outcomes of bacterial and fungal keratitis.
Mabrouk NA, Abdelkader MF, Abdelhakeem MA, Mourad KM, et al · · 2022 · cited 6× · PMID 34839447 · DOI 10.1007/s10792-021-02128-x
Epidemiology, Clinical Profile and Treatment Outcomes of Bacterial and Fungal Keratitis
Mabrouk N, Abdelkader M, Abdelhakeem M, Mourad K, et al · · 2021 · DOI 10.21203/rs.3.rs-573494/v1

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04894630 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 20 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04894630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing